APOGEE BIOTECHNOLOGY CORP.
Apogee is dedicated to developing its sphingosine kinase inhibitor program for the treatment of solid tumors and a variety of chronic inflammatory diseases as well as in indications of damaging acute inflammation. Their product pipeline includes small molecule inhibitors of sphingosine kinase. Sphingosine kinase generates sphingosine-1-phosphate which drives many cancer types and inflammatory diseases and disorders. Their main disease focus is using their technologies to treat solid tumor cancers that have been validated in preclinical animal tumor models including renal cell carcinoma, breast, brain, pancreatic, myeloma and colon cancers.
APOGEE BIOTECHNOLOGY CORP.
Industry:
Biotechnology Clinical Trials Therapeutics
Founded:
2001-01-01
Address:
Hummelstown, Pennsylvania, United States
Country:
United States
Website Url:
http://www.apogee-biotech.com
Total Employee:
11+
Status:
Active
Technology used in webpage:
Euro U.S. Server Location
Similar Organizations
DNAmicroarray
DNAmicroarray is a California corporation with a global presence focused on the development
Neumedicines
Neumedicines is a biotechnology company that focuses on the development of protein therapeutics.
Recensa Therapeutics
Recensa Therapeutics, Inc. has a new approach to treating psoriasis: targeting oxidative stress.
Current Employees Featured
Official Site Inspections
http://www.apogee-biotech.com
- Host name: 144.208.77.246
- IP address: 144.208.77.246
- Location: Los Angeles United States
- Latitude: 33.956
- Longitude: -118.3887
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90045
More informations about "Apogee Biotechnology Corp."
Apogee Biotechnology Corporation
Apogee Biotechnology Corporation was founded in 2001 by Charles D. Smith, Ph.D. and is based at the Hershey Center for Applied Research in Hershey, Pennsylvania. Apogee is developing …See details»
Apogee Therapeutics | Best-in-Class Therapies for Immunological …
Apogee Therapeutics is a clinical stage biotechnology company advancing differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), …See details»
Apogee Biotechnology Corp. - Crunchbase Company …
Apogee is dedicated to developing its sphingosine kinase inhibitor program for the treatment of solid tumors and a variety of chronic inflammatory diseases as …See details»
Investor Relations | Apogee Therapeutics, Inc.
Apogee Therapeutics is a clinical-stage biotechnology company advancing novel biologics with potential for differentiated efficacy and dosing in the largest I&I markets, including for the …See details»
Apogee Technology, Inc.
Apogee is a biotechnology company developing novel drug delivery systems and health sensing solutions to address unmet market health needs. Apogee Technology, Inc. We are developing …See details»
Organization | Apogee Biotechnology Corporation - Purdue …
Apogee Biotechnology Corporation Report issue. ... Organization Overview. First Clinical Trial. 2011 NCT01488513. First Marketed Drug. NoneSee details»
Apogee Biotechnology Corp. - Drug pipelines, Patents, Clinical …
Explore Apogee Biotechnology Corp. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 13 news, and 24 literature, Disease Domain:Neoplasms, Infectious Diseases, …See details»
APOGEE BIOTECHNOLOGY CORPORATION - VentureRadar
"Apogee is developing orally available, small molecules for the treatment of cancer and inflammatory diseases. The Company is privately held and has been financed through mainly …See details»
Apogee Biotechnology Corporation company profile - Tracxn
Feb 19, 2025 Apogee Biotech develops small molecule therapeutics for the treatment of cancer and inflammatory diseases. Its drug discovery approach is focused on small molecule …See details»
Apogee Biotechnology - Craft
Apogee Biotechnology Corporation is a biotech company focused on the treatment of cancer and inflammatory diseases. It is dedicated to developing its sphingosine kinase inhibitor program …See details»
Apogee Therapeutics | Meet the People that Power Progress
Founded in 2022, Apogee leaders recognized that while existing drugs for certain inflammatory and immune diseases may work well, there is an opportunity to do better for patients – …See details»
Apogee Biotechnology Corporation - Overview - aiHit
Apogee Biotechnology Corporation Overview - Apogee Biotechnology Corporation was founded in 2001 by Charles D. Smith, Ph.D. and is based at the Hershey Center for Applied.. ... apogee …See details»
Apogee Therapeutics - Crunchbase Company Profile & Funding
Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders. New. Resources. Advanced Search. ... 519 Number of Organizations • …See details»
Apogee Biotechnology Corp - Company Profile and News
Apogee Biotechnology Corporation was founded in 2001. The company's line of business includes providing commercial physical and biological research and development.See details»
Apogee Technology, Inc.
Apogee is a biotechnology company developing novel drug delivery systems and health sensing solutions to address unmet market health needs. Apogee Technology, Inc. tel 781.769.9100See details»
Apogee Therapeutics | Our Science
Mar 3, 2025 Apogee is progressing a pipeline of novel antibodies engineered against validated targets in some of the largest I&I markets. IL-13. A clinically validated target in atopic …See details»
Apogee Biotechnology Corp.: Drug pipelines, Patents, Clinical trials ...
Explore Apogee Biotechnology Corp. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 7 news, and 8 literature.See details»
Technology – Apogee Biotechnology Corporation
Apogee Biotechnology Corporation novel sphingosine kinase inhibitors: (Lead compound, ABC294640) are the only “drug-like” SK inhibitors reported to date; do not inhibit a broad …See details»
Apogee Therapeutics raises $169M - Labiotech.eu
Dec 7, 2022 Apogee Therapeutics, LLC, a biotech company advancing novel, potentially best-in-class therapies to address immunological and inflammatory disorders, has announced the …See details»
Apogee Therapeutics
Michael Henderson, M.D., joined Apogee in September 2022 and serves as Chief Executive Officer and Board member. He is a proven biotechnology industry leader with expertise in …See details»